1/2
Export Ready

AXILIEVA (AXITINIB TABLETS 5MG)

Sold by RADHAKRUSHNA MEDICALS · Distributor, Exporter, Wholesaler · Yavatmal, Maharashtra, India

Price
Price on request
In stock
Minimum order: 1 Bottle

Export Snapshot

MOQ
1 Bottle
Lead time
On request
Packaging
Standard export packaging
Shelf life / longevity
As per product specification
HSN Code
30049049
Origin
India
Port of dispatch
On request
Export markets served
United States flag US Philippines flag PH Smaller Territories of the UK flag XG United Kingdom flag GB Bangladesh flag BD +46 others
Values shown are for RADHAKRUSHNA MEDICALS.
Suitable for

Importers · Distributors · Wholesalers

Know your supplier

RADHAKRUSHNA MEDICALS is a Distributor, Exporter, Wholesaler based in Yavatmal Maharashtra India.

Yavatmal Dispatch on request Verified seller
RADHAKRUSHNA MEDICALS logo

Distributor, Exporter, Wholesaler · Yavatmal, Maharashtra, India

"Radhakrushna Medicals: Your Destination for Critical Care & Speciality Medicines. Surgical Suture Vaccines  "

Registered address: Yavatmal, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals > Drugs & Pharmaceuticals.

Established
2022
Employees
1–10
GST
27AEMPT2491Q2ZF
IEC code
AEMPT2491Q
Export markets
United States flag US Philippines flag PH Smaller Territories of the UK flag XG United Kingdom flag GB Bangladesh flag BD +46 others
GlobalLinker Member Since
Feb 2026
Turnover
$50,000 - $250,000
Incorporation Type
On request
Product details

What are the specifications of this product?

Overview

Axitinib Tablets 5 mgBrand Name AXILIEVA 5MGComposition Axitinib Tablets 5 mgManufacture By Allieva Pharma Private LimitedForm TabletPacking Btl (28 tab)Country Of Origin India Axitinib, an oral targeted anticancer agent.AXILIEVA 5MGPrescription Required

Product Description

Description
AXILIEVA contains Axitinib, an oral targeted anticancer agent. It is a tyrosine kinase inhibitor (TKI) that selectively blocks vascular endothelial growth factor receptors (VEGFR-1, VEGFR-2, VEGFR-3), inhibiting angiogenesis and tumor growth.

Uses
Axitinib is used for:

Advanced renal cell carcinoma (RCC) – after failure of prior systemic therapy

Other solid tumors – in selected clinical trials or off-label use

Side Effects
Common side effects:

•  Hypertension

•  Fatigue

•  Diarrhea

•  Loss of appetite

•  Nausea and vomiting

•  Hand–foot syndrome

Serious side effects:

•  Severe bleeding

•  Gastrointestinal perforation (rare)

• Proteinuria

•  Liver function abnormalities

•  Cardiovascular events (rare)

Dosage
•  Standard dose: 5 mg orally twice daily

•  Take with or without food

• Dose adjustment may be required in hepatic impairment or based on tolerability 



NOTE: This medicine should be taken only under a doctor’s supervision.

Description provided by RADHAKRUSHNA MEDICALS.

Specifications

Drug Name AXILIEVA
Generic Name Axitinib
Dosage Strength 5 mg
Dosage Form Tablet
Packing Size 28 tablets per bottle
Route of Administration Oral
Pharmacological Action Tyrosine Kinase Inhibitor
Indications Advanced Renal Cell Carcinoma, Selected solid tumors
Adverse Effects Hypertension, fatigue, diarrhea, nausea, hand-foot syndrome
Manufacturer Allieva Pharma Private Limited
Origin India
Prescription Required Yes

Use cases

Category Pharmaceuticals > Oncology Drugs > Anticancer Tablets
Primary application Wholesale, distribution, and international sourcing
Brand Not specified
Product type Product

Logistics & handling

Lead time On request
Packaging As per buyer requirement
Storage condition As recommended by supplier
Origin India
Form As listed by supplier

Commercials (this seller)

Minimum order 1 Bottle
Lead time On request
Payment terms As per negotiated commercial agreement.
Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing AXILIEVA (AXITINIB TABLETS 5MG). Answers compiled from verified sellers' commercial terms and platform data.

Q: Is AXILIEVA suitable for first-line treatment in renal cell carcinoma?
A: AXILIEVA (Axitinib Tablets 5mg) is primarily indicated for use after failure of prior systemic therapy; it is not generally used as first-line treatment.
Q: Can the dosage of AXILIEVA be modified for patients with liver impairment?
A: Yes, dosage adjustment of AXILIEVA is recommended for patients with hepatic impairment or based on patient tolerability.
Q: What is the recommended administration frequency for AXILIEVA 5mg tablets?
A: The standard dosage is 5 mg taken orally twice daily, with or without food.
Q: Are there any serious side effects associated with AXILIEVA?
A: Rare but serious side effects may include severe bleeding, gastrointestinal perforation, proteinuria, and cardiovascular events.
Q: Is AXILIEVA sold as individual tablets or in bulk packaging?
A: AXILIEVA is sold in bottles containing 28 tablets each.
Question not answered? Ask sellers directly — typical response within 4 hours.
AXILIEVA (AXITINIB TABLETS 5MG)
AXILIEVA (AXITINIB TABLETS 5MG)
Price on request · MOQ 1Bottle